oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

4 ( 1 )

2020 ( 5 )

2019 ( 581 )

2018 ( 707 )

Custom range...

Search Results: 1 - 10 of 403044 matches for " Jacqueline M Dekker "
All listed articles are free for downloading (OA Articles)
Page 1 /403044
Display every page Item
Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial
Abeer Ahmad, Jacqueline Hugtenburg, Laura MC Welschen, Jacqueline M Dekker, Giel Nijpels
BMC Public Health , 2010, DOI: 10.1186/1471-2458-10-133
Abstract: A randomized controlled trial will be performed. Community pharmacists will be randomized into a control group and an intervention group. 342 Patients, aged over 60 years, discharged from general and academic hospitals, using five or more prescription drugs for their chronic disease will be asked by their pharmacy to participate in the study.Patients randomized to the control group will receive usual care according to the Dutch Pharmacy Standard. The medication of patients randomised to the intervention group will be reviewed by the community pharmacist with use of the national guidelines for the treatment of diseases, when patients are discharged from the hospital. The Pharmaceutical Care network Europe Registration form will be used to record drug related problems. Trained pharmacy technicians will counsel patients at home at baseline and at 1,3,6,9 and 12 months, using Cognitive Behaviour Treatment according to the Theory of Planned Behaviour. The patient's attitude towards medication and patient's adherence will be subject of the cognitive behaviour treatment. The counselling methods that will be used are motivational interviewing and problem solving treatment. Patients adherence towards drug use will be determined with use of the Medication Adherence Report Scale Questionnaire. There will be a follow-up of 12 months.The two primary outcome measures are the difference in occurrence of DRPs between intervention and control group and adherence with drug use. Secondary endpoints are attitude towards drug use, incidence of Re-hospitalisations related to medicines, functional status of the patient, quality of life and the cost-effectiveness of this intervention.Combining both medication review and Cognitive Behaviour Treatment may decrease DRPs and may result in more compliance with drug use among patients discharged from the hospital and using 5 or more chronic drugs.Dutch Trial Register NTR1194Drug related problems (DRPs) are events or circumstances involving drug
The effectiveness of adding cognitive behavioural therapy aimed at changing lifestyle to managed diabetes care for patients with type 2 diabetes: design of a randomised controlled trial
Laura MC Welschen, Patricia van Oppen, Jacqueline M Dekker, Lex M Bouter, Wim AB Stalman, Giel Nijpels
BMC Public Health , 2007, DOI: 10.1186/1471-2458-7-74
Abstract: Patients with type 2 diabetes will be selected from general practices (n = 13), who are participating in a managed diabetes care system. Patients will be randomised into an intervention group receiving cognitive behaviour therapy (CBT) in addition to managed care, and a control group that will receive managed care only. The CBT consists of three to six individual sessions of 30 minutes to increase the patient's motivation, by using principles of MI, and ability to change their lifestyle, by using PST. The first session will start with a risk assessment of diabetes complications that will be used to focus the intervention.The primary outcome measure is the difference between intervention and control group in change in cardiovascular risk score. For this purpose blood pressure, HbA1c, total and HDL-cholesterol and smoking status will be assessed. Secondary outcome measures are quality of life, patient satisfaction, physical activity, eating behaviour, smoking status, depression and determinants of behaviour change. Differences between changes in the two groups will be analysed according to the intention-to-treat principle, with 95% confidence intervals. The power calculation is based on the risk for cardiovascular disease and we calculated that 97 patients should be included in every group.Cognitive behavioural therapy may improve self-management and thus strengthen managed diabetes care. This should result in changes in lifestyle and cardiovascular risk profile. In addition, we also expect an improvement of quality of life and patient satisfaction.Current Controlled Trials ISRCTN12666286Diabetes mellitus is a major health problem. It was estimated that in 2000 approximately 177 million people worldwide had diabetes, and this number is expected to double by the year 2030 [1]. Cardiovascular disease is the leading cause of death among patients with diabetes. Both cardiovascular disease and diabetes are associated with similar risk factors, namely unhealthy diet, smokin
Depression, Anxiety and Glucose Metabolism in the General Dutch Population: The New Hoorn Study
Vanessa Bouwman,Marcel C. Adriaanse,Esther van ’t Riet,Frank J. Snoek,Jacqueline M. Dekker,Giel Nijpels
PLOS ONE , 2012, DOI: 10.1371/journal.pone.0009971
Abstract: There is a well recognized association between depression and diabetes. However, there is little empirical data about the prevalence of depressive symptoms and anxiety among different groups of glucose metabolism in population based samples. The aim of this study was to determine whether the prevalence of increased levels of depression and anxiety is different between patients with type 2 diabetes and subjects with impaired glucose metabolism (IGM) and normal glucose metabolism (NGM).
The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial
Laura MC Welschen, Sandra DM Bot, Jacqueline M Dekker, Dani?lle RM Timmermans, Trudy van der Weijden, Giel Nijpels
BMC Public Health , 2010, DOI: 10.1186/1471-2458-10-457
Abstract: The aim of this study is to investigate the effects of an intervention focussed on the communication of the absolute 10-year risk to develop CVD on risk perception, attitude and intention to change lifestyle behaviour in patients with T2DM. The conceptual framework of the intervention is based on the Theory of Planned Behaviour and the Self-regulation Theory.A randomised controlled trial will be performed in the Diabetes Care System West-Friesland (DCS), a managed care system. Newly referred T2DM patients of the DCS, younger than 75 years will be eligible for the study. The intervention group will be exposed to risk communication on CVD, on top of standard managed care of the DCS. This intervention consists of a simple explanation on the causes and consequences of CVD, and possibilities for prevention. The probabilities of CVD in 10 year will be explained in natural frequencies and visualised by a population diagram. The control group will receive standard managed care. The primary outcome is appropriateness of risk perception. Secondary outcomes are attitude and intention to change lifestyle behaviour and illness perception. Differences between baseline and follow-up (2 and 12 weeks) between groups will be analysed according to the intention-to-treat principle. The study was powered on 120 patients in each group.This innovative risk communication method based on two behavioural theories might improve patient's appropriateness of risk perception and attitude concerning lifestyle change. With a better understanding of their CVD risk, patients will be able to make informed choices concerning diabetes care.The trial is registered as NTR1556 in the Dutch Trial Register.Patients with type 2 diabetes mellitus (T2DM) have an increased risk to develop severe complications including cardiovascular disease (CVD). The risk of these complications can be reduced by an adequate treatment with medication and by adopting a healthy lifestyle [1-3]. During the last few decades, patie
Web-based guided insulin self-titration in patients with type 2 diabetes: the Di@log study. Design of a cluster randomised controlled trial [TC1316]
Mari?lle GA Roek, Laura MC Welschen, Piet J Kostense, Jacqueline M Dekker, Frank J Snoek, Giel Nijpels
BMC Family Practice , 2009, DOI: 10.1186/1471-2296-10-40
Abstract: T2DM patients (n = 248), aged 35–75 years, with an HbA1c ≥ 7.0%, eligible for treatment with insulin and able to use the internet will be selected from general practices in two different regions in the Netherlands. Cluster randomisation will be performed at the level of general practices. Patients in the intervention group will use a self-developed internet programme to assist them in self-titrating insulin. The control group will receive usual care.Primary outcome is the difference in change in HbA1c between intervention and control group. Secondary outcome measures are quality of life, treatment satisfaction, diabetes self-efficacy and frequency of hypoglycaemic episodes. Results will be analysed according to the intention-to-treat principle.An internet intervention supporting self-titration of insulin therapy in T2DM patients is an innovative patient-centred intervention. The programme provides guided self-monitoring and evaluation of health and self-care behaviours through tailored feedback on input of glucose values. This is expected to result in a better performance of self-titration of insulin and consequently in the improvement of glycaemic control. The patient will be enabled to 'discover and use his or her own ability to gain mastery over his/her diabetes' and therefore patient empowerment will increase. Based on the self-regulation theory of Leventhal, we hypothesize that additional benefits will be achieved in terms of increases in treatment satisfaction, quality of life and self-efficacy.Dutch Trial Register TC1316.The prevalence and incidence of type 2 diabetes mellitus (T2DM) is high and the number of persons with T2DM is growing rapidly to be 366 million in 2030 [1]. International guidelines recommend tight glycaemic control, in order to prevent the onset or to reduce the progression of complications associated with T2DM [2-5]. However, achieving tight glycaemic targets represents a major challenge. A Dutch study found that at least 30 percent of T2D
Effects of self-monitoring of glucose in non-insulin treated patients with type 2 diabetes: design of the IN CONTROL-trial
Uri?ll L Malanda, Sandra DM Bot, Piet J Kostense, Frank J Snoek, Jacqueline M Dekker, Giel Nijpels
BMC Family Practice , 2009, DOI: 10.1186/1471-2296-10-26
Abstract: Six hundred patients with T2DM (45 ≤ 75 years) who receive care in a structured diabetes care system, HbA1c ≥ 7.0%, and not using insulin will be recruited and randomized into 3 groups; Self-monitoring of Blood Glucose (SMBG), Self-monitoring of Urine Glucose (SMUG) and usual care (n = 200 per group). Participants are eligible if they have a known disease duration of over 1 year and have used SMBG or SMUG less than 3 times in the previous year. All 3 groups will receive standardized diabetes care. The intervention groups will receive additional instructions on how to perform self-monitoring of glucose and how to interpret the results. Main outcome measures are changes in diabetes specific emotional distress and self-efficacy. Secondary outcome measures include difference in HbA1c, patient satisfaction, occurrence of hypoglycaemia, physical activity, costs of direct and indirect healthcare and changes in illness beliefs.The IN CONTROL-trial is designed to explore whether feedback from self-monitoring of glucose in T2DM patients who do not require insulin can affect diabetes specific emotional distress and increase self-efficacy. Based on the self-regulation model it is hypothesized that glucose self-monitoring feedback changes illness perceptions, guiding the patient to reduce emotional responses to experienced threats, and influences the patients ability to perform and maintain self-management skills.Current Controlled Trials ISRCTN84568563Diabetes specific emotional problems can interfere with the strict regime type 2 diabetes mellitus (T2DM) demands. Emotional problems, such as not accepting diabetes, fear for hypoglycaemia and worrying about complications, might impact aspects of quality of life, for example, increase diabetes related distress, which in turn might affect self-care behaviours and glycaemic control [1,2]. Diabetes self-management can protect against the development of diabetes specific distress [3] and it can have a positive effect on perceived sel
Primary prevention of diabetes mellitus type 2 and cardiovascular diseases using a cognitive behavior program aimed at lifestyle changes in people at risk: Design of a randomized controlled trial
Jeroen Lakerveld, Sandra DM Bot, Marijke J Chinapaw, Maurits W van Tulder, Patricia van Oppen, Jacqueline M Dekker, Giel Nijpels
BMC Endocrine Disorders , 2008, DOI: 10.1186/1472-6823-8-6
Abstract: 12,000 inhabitants, 30-50 years of age living in several municipalities in the semi-rural region of West-Friesland will receive an invitation from their general practitioner (n = 13) to measure their own waist circumference with a tape measure. People with abdominal obesity (male waist ≥ 102 cm, female waist ≥ 88 cm) will be invited to participate in the second step of the screening which includes blood pressure, a blood sample and anthropometric measurements. T2DM and CVD risk scores will then be calculated according to the ARIC and the SCORE formulae, respectively. People with a score that indicates a high risk of developing T2DM and/or CVD will then be randomly assigned to the intervention group (n = 300) or the control group (n = 300).Participants in the intervention group will follow a CBP aimed at modifying their dietary behavior, physical activity, and smoking behavior. The counseling methods that will be used are motivational interviewing (MI) and problem solving treatment (PST), which focus in particular on intrinsic motivation for change and self-management of problems of the participants. The CBP will be provided by trained nurse practitioners in the participant's general practice, and will consists of a maximum of six individual sessions of 30 minutes, followed by 3-monthly booster sessions by phone. Participants in the control group will receive brochures containing health guidelines regarding physical activity and diet, and how to stop smoking. The primary outcome measures will be changes in T2DM and CVD risk scores. Secondary outcome measures will be changes in lifestyle behavior and cost-effectiveness and cost-utility ratios. All relevant direct and indirect costs will be measured, and there will be a follow-up of 24 months.Changing behaviors is difficult, requires time, considerable effort and motivation. Combining the two counseling methods MI and PST, followed by booster sessions may result in sustained behavioral change.Current Controlled Trials
L. Turksma, Q.M.R. Ver Huell. Levensherinneringen 1787-1812
R.M. Dekker
BMGN : Low Countries Historical Review , 1998,
Abstract:
'Getrouwe broederschap'. Organisatie en acties van arbeiders in pre ndustrieel Holland
R.M. Dekker
BMGN : Low Countries Historical Review , 1988,
Abstract:
Wie schreef de Gedenkschriften van een voornaam Nederlandsch beambte? Enkele opmerkingen naar aanleiding van een recente heruitgave
R.M. Dekker
BMGN : Low Countries Historical Review , 1983,
Abstract:
Page 1 /403044
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.